nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP2D6—Hydroxyurea—head and neck cancer	0.158	0.228	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.1	0.144	CbGbCtD
Zolpidem—CYP3A7—Docetaxel—head and neck cancer	0.1	0.144	CbGbCtD
Zolpidem—CYP3A5—Docetaxel—head and neck cancer	0.0751	0.108	CbGbCtD
Zolpidem—CYP1A2—Fluorouracil—head and neck cancer	0.0732	0.106	CbGbCtD
Zolpidem—CYP2C9—Fluorouracil—head and neck cancer	0.066	0.0952	CbGbCtD
Zolpidem—CYP2D6—Vinblastine—head and neck cancer	0.0559	0.0806	CbGbCtD
Zolpidem—CYP3A4—Vinblastine—head and neck cancer	0.0355	0.0513	CbGbCtD
Zolpidem—CYP3A4—Docetaxel—head and neck cancer	0.0293	0.0423	CbGbCtD
Zolpidem—Tolmetin—PTGS2—head and neck cancer	0.00422	1	CrCbGaD
Zolpidem—Renal failure acute—Hydroxyurea—head and neck cancer	0.00203	0.00758	CcSEcCtD
Zolpidem—Herpes simplex—Fluorouracil—head and neck cancer	0.00202	0.00753	CcSEcCtD
Zolpidem—Intestinal obstruction—Docetaxel—head and neck cancer	0.00197	0.00735	CcSEcCtD
Zolpidem—Dysarthria—Fluorouracil—head and neck cancer	0.00197	0.00734	CcSEcCtD
Zolpidem—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00196	0.00733	CcSEcCtD
Zolpidem—Burning sensation—Docetaxel—head and neck cancer	0.00193	0.00721	CcSEcCtD
Zolpidem—Neuralgia—Docetaxel—head and neck cancer	0.00193	0.00721	CcSEcCtD
Zolpidem—Face oedema—Hydroxyurea—head and neck cancer	0.00181	0.00676	CcSEcCtD
Zolpidem—Neuritis—Docetaxel—head and neck cancer	0.0018	0.00671	CcSEcCtD
Zolpidem—Angina pectoris—Vinblastine—head and neck cancer	0.00173	0.00646	CcSEcCtD
Zolpidem—Otitis media—Docetaxel—head and neck cancer	0.00173	0.00644	CcSEcCtD
Zolpidem—Breast disorder—Hydroxyurea—head and neck cancer	0.0017	0.00633	CcSEcCtD
Zolpidem—Rigors—Docetaxel—head and neck cancer	0.00165	0.00614	CcSEcCtD
Zolpidem—Euphoric mood—Fluorouracil—head and neck cancer	0.0016	0.00596	CcSEcCtD
Zolpidem—Depression—Vinblastine—head and neck cancer	0.00158	0.0059	CcSEcCtD
Zolpidem—Eye irritation—Docetaxel—head and neck cancer	0.00157	0.00587	CcSEcCtD
Zolpidem—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00156	0.00583	CcSEcCtD
Zolpidem—Myocardial infarction—Vinblastine—head and neck cancer	0.00156	0.0058	CcSEcCtD
Zolpidem—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00156	0.0058	CcSEcCtD
Zolpidem—Chest discomfort—Docetaxel—head and neck cancer	0.00152	0.00566	CcSEcCtD
Zolpidem—Dysuria—Hydroxyurea—head and neck cancer	0.00152	0.00566	CcSEcCtD
Zolpidem—Disorientation—Fluorouracil—head and neck cancer	0.00151	0.00563	CcSEcCtD
Zolpidem—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00148	0.00551	CcSEcCtD
Zolpidem—Drug interaction—Docetaxel—head and neck cancer	0.00145	0.0054	CcSEcCtD
Zolpidem—Infestation—Hydroxyurea—head and neck cancer	0.00145	0.0054	CcSEcCtD
Zolpidem—Drowsiness—Hydroxyurea—head and neck cancer	0.00145	0.0054	CcSEcCtD
Zolpidem—Infestation NOS—Hydroxyurea—head and neck cancer	0.00145	0.0054	CcSEcCtD
Zolpidem—Amnesia—Fluorouracil—head and neck cancer	0.00144	0.00536	CcSEcCtD
Zolpidem—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00142	0.00529	CcSEcCtD
Zolpidem—Hypoaesthesia—Vinblastine—head and neck cancer	0.00142	0.00528	CcSEcCtD
Zolpidem—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00141	0.00527	CcSEcCtD
Zolpidem—Pharyngitis—Vinblastine—head and neck cancer	0.00141	0.00527	CcSEcCtD
Zolpidem—Stomatitis—Hydroxyurea—head and neck cancer	0.00141	0.00526	CcSEcCtD
Zolpidem—Lethargy—Fluorouracil—head and neck cancer	0.00138	0.00514	CcSEcCtD
Zolpidem—Osteoarthritis—Fluorouracil—head and neck cancer	0.00135	0.00504	CcSEcCtD
Zolpidem—Blood pressure increased—Docetaxel—head and neck cancer	0.00134	0.00501	CcSEcCtD
Zolpidem—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00134	0.00501	CcSEcCtD
Zolpidem—Pulmonary embolism—Docetaxel—head and neck cancer	0.00134	0.00501	CcSEcCtD
Zolpidem—Influenza like illness—Docetaxel—head and neck cancer	0.00131	0.00487	CcSEcCtD
Zolpidem—Hallucination—Hydroxyurea—head and neck cancer	0.00129	0.00482	CcSEcCtD
Zolpidem—Irritability—Fluorouracil—head and neck cancer	0.00129	0.00481	CcSEcCtD
Zolpidem—Ataxia—Fluorouracil—head and neck cancer	0.00127	0.00474	CcSEcCtD
Zolpidem—Neuropathy—Docetaxel—head and neck cancer	0.00126	0.0047	CcSEcCtD
Zolpidem—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00121	0.00451	CcSEcCtD
Zolpidem—Lightheadedness—Docetaxel—head and neck cancer	0.0012	0.00448	CcSEcCtD
Zolpidem—Pulmonary oedema—Docetaxel—head and neck cancer	0.0012	0.00446	CcSEcCtD
Zolpidem—Muscular weakness—Fluorouracil—head and neck cancer	0.00119	0.00444	CcSEcCtD
Zolpidem—Dysphagia—Fluorouracil—head and neck cancer	0.00117	0.00436	CcSEcCtD
Zolpidem—Chills—Hydroxyurea—head and neck cancer	0.00117	0.00435	CcSEcCtD
Zolpidem—Ill-defined disorder—Vinblastine—head and neck cancer	0.00115	0.00429	CcSEcCtD
Zolpidem—Anaemia—Vinblastine—head and neck cancer	0.00115	0.00427	CcSEcCtD
Zolpidem—Angina pectoris—Fluorouracil—head and neck cancer	0.00114	0.00424	CcSEcCtD
Zolpidem—Phlebitis—Docetaxel—head and neck cancer	0.00113	0.00422	CcSEcCtD
Zolpidem—Erythema—Hydroxyurea—head and neck cancer	0.00113	0.00422	CcSEcCtD
Zolpidem—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00112	0.00418	CcSEcCtD
Zolpidem—Malaise—Vinblastine—head and neck cancer	0.00112	0.00417	CcSEcCtD
Zolpidem—Vertigo—Vinblastine—head and neck cancer	0.00111	0.00415	CcSEcCtD
Zolpidem—Leukopenia—Vinblastine—head and neck cancer	0.00111	0.00414	CcSEcCtD
Zolpidem—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00109	0.00405	CcSEcCtD
Zolpidem—Hypertension—Vinblastine—head and neck cancer	0.00107	0.00399	CcSEcCtD
Zolpidem—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00107	0.00398	CcSEcCtD
Zolpidem—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00105	0.00391	CcSEcCtD
Zolpidem—Pneumonia—Fluorouracil—head and neck cancer	0.00105	0.00391	CcSEcCtD
Zolpidem—Anaemia—Hydroxyurea—head and neck cancer	0.00105	0.0039	CcSEcCtD
Zolpidem—Discomfort—Vinblastine—head and neck cancer	0.00104	0.00389	CcSEcCtD
Zolpidem—Hot flush—Docetaxel—head and neck cancer	0.00104	0.00389	CcSEcCtD
Zolpidem—Infestation NOS—Fluorouracil—head and neck cancer	0.00104	0.00388	CcSEcCtD
Zolpidem—Infestation—Fluorouracil—head and neck cancer	0.00104	0.00388	CcSEcCtD
Zolpidem—Menopausal symptoms—Docetaxel—head and neck cancer	0.00103	0.00385	CcSEcCtD
Zolpidem—Visual disturbance—Docetaxel—head and neck cancer	0.00103	0.00384	CcSEcCtD
Zolpidem—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00103	0.00383	CcSEcCtD
Zolpidem—Myocardial infarction—Fluorouracil—head and neck cancer	0.00102	0.00381	CcSEcCtD
Zolpidem—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00102	0.00381	CcSEcCtD
Zolpidem—Dermatitis bullous—Docetaxel—head and neck cancer	0.00102	0.00381	CcSEcCtD
Zolpidem—Malaise—Hydroxyurea—head and neck cancer	0.00102	0.0038	CcSEcCtD
Zolpidem—Stomatitis—Fluorouracil—head and neck cancer	0.00102	0.00379	CcSEcCtD
Zolpidem—Urinary tract infection—Fluorouracil—head and neck cancer	0.00101	0.00377	CcSEcCtD
Zolpidem—Conjunctivitis—Fluorouracil—head and neck cancer	0.00101	0.00377	CcSEcCtD
Zolpidem—Leukopenia—Hydroxyurea—head and neck cancer	0.00101	0.00377	CcSEcCtD
Zolpidem—Lethargy—Docetaxel—head and neck cancer	0.000995	0.00371	CcSEcCtD
Zolpidem—Epistaxis—Fluorouracil—head and neck cancer	0.000982	0.00366	CcSEcCtD
Zolpidem—Sinusitis—Fluorouracil—head and neck cancer	0.000977	0.00364	CcSEcCtD
Zolpidem—Anorexia—Vinblastine—head and neck cancer	0.000965	0.0036	CcSEcCtD
Zolpidem—Migraine—Docetaxel—head and neck cancer	0.00096	0.00358	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000956	0.00356	CcSEcCtD
Zolpidem—Discomfort—Hydroxyurea—head and neck cancer	0.000951	0.00355	CcSEcCtD
Zolpidem—Rhinitis—Fluorouracil—head and neck cancer	0.000937	0.00349	CcSEcCtD
Zolpidem—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00093	0.00347	CcSEcCtD
Zolpidem—Pharyngitis—Fluorouracil—head and neck cancer	0.000928	0.00346	CcSEcCtD
Zolpidem—Oedema—Hydroxyurea—head and neck cancer	0.000923	0.00344	CcSEcCtD
Zolpidem—Ataxia—Docetaxel—head and neck cancer	0.000917	0.00342	CcSEcCtD
Zolpidem—Infection—Hydroxyurea—head and neck cancer	0.000917	0.00342	CcSEcCtD
Zolpidem—Paraesthesia—Vinblastine—head and neck cancer	0.000909	0.00339	CcSEcCtD
Zolpidem—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000905	0.00337	CcSEcCtD
Zolpidem—Skin disorder—Hydroxyurea—head and neck cancer	0.000896	0.00334	CcSEcCtD
Zolpidem—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000891	0.00332	CcSEcCtD
Zolpidem—Breast disorder—Docetaxel—head and neck cancer	0.000881	0.00329	CcSEcCtD
Zolpidem—Anorexia—Hydroxyurea—head and neck cancer	0.00088	0.00328	CcSEcCtD
Zolpidem—Decreased appetite—Vinblastine—head and neck cancer	0.00088	0.00328	CcSEcCtD
Zolpidem—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000878	0.00328	CcSEcCtD
Zolpidem—Cramp muscle—Docetaxel—head and neck cancer	0.000878	0.00328	CcSEcCtD
Zolpidem—Nasopharyngitis—Docetaxel—head and neck cancer	0.000872	0.00325	CcSEcCtD
Zolpidem—Pain—Vinblastine—head and neck cancer	0.000865	0.00323	CcSEcCtD
Zolpidem—Constipation—Vinblastine—head and neck cancer	0.000865	0.00323	CcSEcCtD
Zolpidem—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00086	0.00321	CcSEcCtD
Zolpidem—Dysphagia—Docetaxel—head and neck cancer	0.000843	0.00314	CcSEcCtD
Zolpidem—Arrhythmia—Fluorouracil—head and neck cancer	0.000835	0.00311	CcSEcCtD
Zolpidem—Feeling abnormal—Vinblastine—head and neck cancer	0.000834	0.00311	CcSEcCtD
Zolpidem—Bronchospasm—Docetaxel—head and neck cancer	0.000829	0.00309	CcSEcCtD
Zolpidem—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000827	0.00309	CcSEcCtD
Zolpidem—Dyspnoea—Hydroxyurea—head and neck cancer	0.000823	0.00307	CcSEcCtD
Zolpidem—Angina pectoris—Docetaxel—head and neck cancer	0.000821	0.00306	CcSEcCtD
Zolpidem—Somnolence—Hydroxyurea—head and neck cancer	0.00082	0.00306	CcSEcCtD
Zolpidem—Erythema—Fluorouracil—head and neck cancer	0.000814	0.00303	CcSEcCtD
Zolpidem—Dyspepsia—Hydroxyurea—head and neck cancer	0.000812	0.00303	CcSEcCtD
Zolpidem—Decreased appetite—Hydroxyurea—head and neck cancer	0.000802	0.00299	CcSEcCtD
Zolpidem—Abdominal pain—Vinblastine—head and neck cancer	0.0008	0.00298	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000797	0.00297	CcSEcCtD
Zolpidem—Fatigue—Hydroxyurea—head and neck cancer	0.000796	0.00297	CcSEcCtD
Zolpidem—Pain—Hydroxyurea—head and neck cancer	0.000789	0.00294	CcSEcCtD
Zolpidem—Constipation—Hydroxyurea—head and neck cancer	0.000789	0.00294	CcSEcCtD
Zolpidem—Vision blurred—Fluorouracil—head and neck cancer	0.000767	0.00286	CcSEcCtD
Zolpidem—Weight decreased—Docetaxel—head and neck cancer	0.000763	0.00284	CcSEcCtD
Zolpidem—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00076	0.00284	CcSEcCtD
Zolpidem—Pneumonia—Docetaxel—head and neck cancer	0.000756	0.00282	CcSEcCtD
Zolpidem—Anaemia—Fluorouracil—head and neck cancer	0.000752	0.0028	CcSEcCtD
Zolpidem—Infestation NOS—Docetaxel—head and neck cancer	0.000752	0.0028	CcSEcCtD
Zolpidem—Infestation—Docetaxel—head and neck cancer	0.000752	0.0028	CcSEcCtD
Zolpidem—Hypersensitivity—Vinblastine—head and neck cancer	0.000746	0.00278	CcSEcCtD
Zolpidem—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000741	0.00276	CcSEcCtD
Zolpidem—Myocardial infarction—Docetaxel—head and neck cancer	0.000737	0.00275	CcSEcCtD
Zolpidem—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000737	0.00275	CcSEcCtD
Zolpidem—Stomatitis—Docetaxel—head and neck cancer	0.000733	0.00273	CcSEcCtD
Zolpidem—Conjunctivitis—Docetaxel—head and neck cancer	0.000731	0.00272	CcSEcCtD
Zolpidem—Body temperature increased—Hydroxyurea—head and neck cancer	0.00073	0.00272	CcSEcCtD
Zolpidem—Leukopenia—Fluorouracil—head and neck cancer	0.000729	0.00272	CcSEcCtD
Zolpidem—Asthenia—Vinblastine—head and neck cancer	0.000726	0.00271	CcSEcCtD
Zolpidem—Epistaxis—Docetaxel—head and neck cancer	0.000709	0.00264	CcSEcCtD
Zolpidem—Myalgia—Fluorouracil—head and neck cancer	0.000693	0.00258	CcSEcCtD
Zolpidem—Chest pain—Fluorouracil—head and neck cancer	0.000693	0.00258	CcSEcCtD
Zolpidem—Diarrhoea—Vinblastine—head and neck cancer	0.000692	0.00258	CcSEcCtD
Zolpidem—Discomfort—Fluorouracil—head and neck cancer	0.000685	0.00255	CcSEcCtD
Zolpidem—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00068	0.00254	CcSEcCtD
Zolpidem—Rhinitis—Docetaxel—head and neck cancer	0.000677	0.00252	CcSEcCtD
Zolpidem—Hypoaesthesia—Docetaxel—head and neck cancer	0.000671	0.0025	CcSEcCtD
Zolpidem—Confusional state—Fluorouracil—head and neck cancer	0.00067	0.0025	CcSEcCtD
Zolpidem—Pharyngitis—Docetaxel—head and neck cancer	0.00067	0.0025	CcSEcCtD
Zolpidem—Dizziness—Vinblastine—head and neck cancer	0.000669	0.0025	CcSEcCtD
Zolpidem—Urinary tract disorder—Docetaxel—head and neck cancer	0.000666	0.00248	CcSEcCtD
Zolpidem—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000664	0.00248	CcSEcCtD
Zolpidem—Oedema—Fluorouracil—head and neck cancer	0.000664	0.00248	CcSEcCtD
Zolpidem—Connective tissue disorder—Docetaxel—head and neck cancer	0.000663	0.00247	CcSEcCtD
Zolpidem—Asthenia—Hydroxyurea—head and neck cancer	0.000662	0.00247	CcSEcCtD
Zolpidem—Urethral disorder—Docetaxel—head and neck cancer	0.000661	0.00247	CcSEcCtD
Zolpidem—Infection—Fluorouracil—head and neck cancer	0.00066	0.00246	CcSEcCtD
Zolpidem—Nervous system disorder—Fluorouracil—head and neck cancer	0.000651	0.00243	CcSEcCtD
Zolpidem—Visual impairment—Docetaxel—head and neck cancer	0.00065	0.00242	CcSEcCtD
Zolpidem—Tachycardia—Fluorouracil—head and neck cancer	0.000648	0.00242	CcSEcCtD
Zolpidem—Vomiting—Vinblastine—head and neck cancer	0.000643	0.0024	CcSEcCtD
Zolpidem—Headache—Vinblastine—head and neck cancer	0.000634	0.00236	CcSEcCtD
Zolpidem—Anorexia—Fluorouracil—head and neck cancer	0.000633	0.00236	CcSEcCtD
Zolpidem—Diarrhoea—Hydroxyurea—head and neck cancer	0.000631	0.00235	CcSEcCtD
Zolpidem—Eye disorder—Docetaxel—head and neck cancer	0.000631	0.00235	CcSEcCtD
Zolpidem—Cardiac disorder—Docetaxel—head and neck cancer	0.000626	0.00234	CcSEcCtD
Zolpidem—Flushing—Docetaxel—head and neck cancer	0.000626	0.00234	CcSEcCtD
Zolpidem—Hypotension—Fluorouracil—head and neck cancer	0.000621	0.00231	CcSEcCtD
Zolpidem—Dizziness—Hydroxyurea—head and neck cancer	0.00061	0.00228	CcSEcCtD
Zolpidem—Mediastinal disorder—Docetaxel—head and neck cancer	0.000608	0.00227	CcSEcCtD
Zolpidem—Chills—Docetaxel—head and neck cancer	0.000605	0.00226	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000605	0.00226	CcSEcCtD
Zolpidem—Arrhythmia—Docetaxel—head and neck cancer	0.000603	0.00225	CcSEcCtD
Zolpidem—Nausea—Vinblastine—head and neck cancer	0.000601	0.00224	CcSEcCtD
Zolpidem—Insomnia—Fluorouracil—head and neck cancer	0.000601	0.00224	CcSEcCtD
Zolpidem—Paraesthesia—Fluorouracil—head and neck cancer	0.000596	0.00222	CcSEcCtD
Zolpidem—Dyspnoea—Fluorouracil—head and neck cancer	0.000592	0.00221	CcSEcCtD
Zolpidem—Mental disorder—Docetaxel—head and neck cancer	0.000591	0.0022	CcSEcCtD
Zolpidem—Somnolence—Fluorouracil—head and neck cancer	0.000591	0.0022	CcSEcCtD
Zolpidem—Malnutrition—Docetaxel—head and neck cancer	0.000587	0.00219	CcSEcCtD
Zolpidem—Erythema—Docetaxel—head and neck cancer	0.000587	0.00219	CcSEcCtD
Zolpidem—Vomiting—Hydroxyurea—head and neck cancer	0.000587	0.00219	CcSEcCtD
Zolpidem—Dyspepsia—Fluorouracil—head and neck cancer	0.000585	0.00218	CcSEcCtD
Zolpidem—Rash—Hydroxyurea—head and neck cancer	0.000582	0.00217	CcSEcCtD
Zolpidem—Dermatitis—Hydroxyurea—head and neck cancer	0.000581	0.00217	CcSEcCtD
Zolpidem—Headache—Hydroxyurea—head and neck cancer	0.000578	0.00216	CcSEcCtD
Zolpidem—Decreased appetite—Fluorouracil—head and neck cancer	0.000577	0.00215	CcSEcCtD
Zolpidem—Dysgeusia—Docetaxel—head and neck cancer	0.000575	0.00214	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000573	0.00214	CcSEcCtD
Zolpidem—Back pain—Docetaxel—head and neck cancer	0.000568	0.00212	CcSEcCtD
Zolpidem—Pain—Fluorouracil—head and neck cancer	0.000568	0.00212	CcSEcCtD
Zolpidem—Muscle spasms—Docetaxel—head and neck cancer	0.000565	0.00211	CcSEcCtD
Zolpidem—Nausea—Hydroxyurea—head and neck cancer	0.000548	0.00204	CcSEcCtD
Zolpidem—Feeling abnormal—Fluorouracil—head and neck cancer	0.000547	0.00204	CcSEcCtD
Zolpidem—Anaemia—Docetaxel—head and neck cancer	0.000543	0.00202	CcSEcCtD
Zolpidem—Urticaria—Fluorouracil—head and neck cancer	0.000528	0.00197	CcSEcCtD
Zolpidem—Syncope—Docetaxel—head and neck cancer	0.000527	0.00196	CcSEcCtD
Zolpidem—Leukopenia—Docetaxel—head and neck cancer	0.000526	0.00196	CcSEcCtD
Zolpidem—Body temperature increased—Fluorouracil—head and neck cancer	0.000525	0.00196	CcSEcCtD
Zolpidem—Palpitations—Docetaxel—head and neck cancer	0.000519	0.00194	CcSEcCtD
Zolpidem—Loss of consciousness—Docetaxel—head and neck cancer	0.000516	0.00193	CcSEcCtD
Zolpidem—Cough—Docetaxel—head and neck cancer	0.000513	0.00191	CcSEcCtD
Zolpidem—Hypertension—Docetaxel—head and neck cancer	0.000507	0.00189	CcSEcCtD
Zolpidem—Myalgia—Docetaxel—head and neck cancer	0.0005	0.00186	CcSEcCtD
Zolpidem—Chest pain—Docetaxel—head and neck cancer	0.0005	0.00186	CcSEcCtD
Zolpidem—Arthralgia—Docetaxel—head and neck cancer	0.0005	0.00186	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000497	0.00185	CcSEcCtD
Zolpidem—Hypersensitivity—Fluorouracil—head and neck cancer	0.000489	0.00182	CcSEcCtD
Zolpidem—Dry mouth—Docetaxel—head and neck cancer	0.000489	0.00182	CcSEcCtD
Zolpidem—Confusional state—Docetaxel—head and neck cancer	0.000483	0.0018	CcSEcCtD
Zolpidem—Anaphylactic shock—Docetaxel—head and neck cancer	0.000479	0.00179	CcSEcCtD
Zolpidem—Oedema—Docetaxel—head and neck cancer	0.000479	0.00179	CcSEcCtD
Zolpidem—Infection—Docetaxel—head and neck cancer	0.000476	0.00178	CcSEcCtD
Zolpidem—Shock—Docetaxel—head and neck cancer	0.000472	0.00176	CcSEcCtD
Zolpidem—Nervous system disorder—Docetaxel—head and neck cancer	0.00047	0.00175	CcSEcCtD
Zolpidem—Pruritus—Fluorouracil—head and neck cancer	0.00047	0.00175	CcSEcCtD
Zolpidem—Tachycardia—Docetaxel—head and neck cancer	0.000468	0.00174	CcSEcCtD
Zolpidem—Skin disorder—Docetaxel—head and neck cancer	0.000466	0.00174	CcSEcCtD
Zolpidem—Anorexia—Docetaxel—head and neck cancer	0.000457	0.0017	CcSEcCtD
Zolpidem—Diarrhoea—Fluorouracil—head and neck cancer	0.000454	0.00169	CcSEcCtD
Zolpidem—Hypotension—Docetaxel—head and neck cancer	0.000448	0.00167	CcSEcCtD
Zolpidem—Dizziness—Fluorouracil—head and neck cancer	0.000439	0.00164	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000437	0.00163	CcSEcCtD
Zolpidem—Insomnia—Docetaxel—head and neck cancer	0.000434	0.00162	CcSEcCtD
Zolpidem—Paraesthesia—Docetaxel—head and neck cancer	0.000431	0.00161	CcSEcCtD
Zolpidem—Dyspnoea—Docetaxel—head and neck cancer	0.000427	0.00159	CcSEcCtD
Zolpidem—Somnolence—Docetaxel—head and neck cancer	0.000426	0.00159	CcSEcCtD
Zolpidem—Vomiting—Fluorouracil—head and neck cancer	0.000422	0.00157	CcSEcCtD
Zolpidem—Dyspepsia—Docetaxel—head and neck cancer	0.000422	0.00157	CcSEcCtD
Zolpidem—Rash—Fluorouracil—head and neck cancer	0.000419	0.00156	CcSEcCtD
Zolpidem—Dermatitis—Fluorouracil—head and neck cancer	0.000418	0.00156	CcSEcCtD
Zolpidem—Decreased appetite—Docetaxel—head and neck cancer	0.000417	0.00155	CcSEcCtD
Zolpidem—Headache—Fluorouracil—head and neck cancer	0.000416	0.00155	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000414	0.00154	CcSEcCtD
Zolpidem—Fatigue—Docetaxel—head and neck cancer	0.000413	0.00154	CcSEcCtD
Zolpidem—Pain—Docetaxel—head and neck cancer	0.00041	0.00153	CcSEcCtD
Zolpidem—Constipation—Docetaxel—head and neck cancer	0.00041	0.00153	CcSEcCtD
Zolpidem—Feeling abnormal—Docetaxel—head and neck cancer	0.000395	0.00147	CcSEcCtD
Zolpidem—Nausea—Fluorouracil—head and neck cancer	0.000395	0.00147	CcSEcCtD
Zolpidem—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000392	0.00146	CcSEcCtD
Zolpidem—Body temperature increased—Docetaxel—head and neck cancer	0.000379	0.00141	CcSEcCtD
Zolpidem—Abdominal pain—Docetaxel—head and neck cancer	0.000379	0.00141	CcSEcCtD
Zolpidem—Hypersensitivity—Docetaxel—head and neck cancer	0.000353	0.00132	CcSEcCtD
Zolpidem—Asthenia—Docetaxel—head and neck cancer	0.000344	0.00128	CcSEcCtD
Zolpidem—Pruritus—Docetaxel—head and neck cancer	0.000339	0.00126	CcSEcCtD
Zolpidem—Diarrhoea—Docetaxel—head and neck cancer	0.000328	0.00122	CcSEcCtD
Zolpidem—Dizziness—Docetaxel—head and neck cancer	0.000317	0.00118	CcSEcCtD
Zolpidem—Vomiting—Docetaxel—head and neck cancer	0.000305	0.00114	CcSEcCtD
Zolpidem—Rash—Docetaxel—head and neck cancer	0.000302	0.00113	CcSEcCtD
Zolpidem—Dermatitis—Docetaxel—head and neck cancer	0.000302	0.00113	CcSEcCtD
Zolpidem—Headache—Docetaxel—head and neck cancer	0.0003	0.00112	CcSEcCtD
Zolpidem—Nausea—Docetaxel—head and neck cancer	0.000285	0.00106	CcSEcCtD
Zolpidem—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000169	0.00494	CbGpPWpGaD
Zolpidem—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000165	0.00481	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.000164	0.00479	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.000162	0.00473	CbGpPWpGaD
Zolpidem—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000161	0.00471	CbGpPWpGaD
Zolpidem—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00016	0.00466	CbGpPWpGaD
Zolpidem—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000147	0.00429	CbGpPWpGaD
Zolpidem—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000146	0.00425	CbGpPWpGaD
Zolpidem—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000145	0.00423	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000143	0.00417	CbGpPWpGaD
Zolpidem—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000138	0.00403	CbGpPWpGaD
Zolpidem—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000136	0.00398	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000136	0.00398	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000134	0.00391	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000133	0.00388	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000133	0.00388	CbGpPWpGaD
Zolpidem—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000133	0.00388	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000133	0.00388	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00013	0.00381	CbGpPWpGaD
Zolpidem—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000127	0.00371	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000127	0.00371	CbGpPWpGaD
Zolpidem—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000126	0.00367	CbGpPWpGaD
Zolpidem—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000126	0.00367	CbGpPWpGaD
Zolpidem—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000125	0.00366	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000125	0.00366	CbGpPWpGaD
Zolpidem—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000124	0.00363	CbGpPWpGaD
Zolpidem—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000124	0.00363	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000117	0.00341	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000116	0.00338	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000115	0.00336	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000114	0.00333	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000114	0.00333	CbGpPWpGaD
Zolpidem—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	0.000112	0.00328	CbGpPWpGaD
Zolpidem—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000112	0.00327	CbGpPWpGaD
Zolpidem—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000111	0.00323	CbGpPWpGaD
Zolpidem—PTGS1—Biological oxidations—GSTM1—head and neck cancer	0.000109	0.00317	CbGpPWpGaD
Zolpidem—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000107	0.00314	CbGpPWpGaD
Zolpidem—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	0.000106	0.00311	CbGpPWpGaD
Zolpidem—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000106	0.0031	CbGpPWpGaD
Zolpidem—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000105	0.00306	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000105	0.00306	CbGpPWpGaD
Zolpidem—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	0.000103	0.00301	CbGpPWpGaD
Zolpidem—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000103	0.003	CbGpPWpGaD
Zolpidem—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000103	0.003	CbGpPWpGaD
Zolpidem—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000102	0.00298	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—NAT2—head and neck cancer	9.89e-05	0.00289	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	9.75e-05	0.00285	CbGpPWpGaD
Zolpidem—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.49e-05	0.00277	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—UROD—head and neck cancer	9.35e-05	0.00273	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—UROD—head and neck cancer	9.06e-05	0.00265	CbGpPWpGaD
Zolpidem—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	8.71e-05	0.00255	CbGpPWpGaD
Zolpidem—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	8.65e-05	0.00253	CbGpPWpGaD
Zolpidem—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	8.35e-05	0.00244	CbGpPWpGaD
Zolpidem—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	8.3e-05	0.00242	CbGpPWpGaD
Zolpidem—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	8.19e-05	0.00239	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	8.1e-05	0.00237	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	7.99e-05	0.00234	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	7.91e-05	0.00231	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	7.68e-05	0.00224	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—NAT2—head and neck cancer	7.63e-05	0.00223	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	7.58e-05	0.00221	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	7.52e-05	0.0022	CbGpPWpGaD
Zolpidem—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	7.4e-05	0.00216	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	7.33e-05	0.00214	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—STAT3—head and neck cancer	7.2e-05	0.0021	CbGpPWpGaD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	7.19e-05	0.0021	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.03e-05	0.00205	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—MAPK3—head and neck cancer	6.88e-05	0.00201	CbGpPWpGaD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	6.86e-05	0.002	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—UROD—head and neck cancer	6.76e-05	0.00197	CbGpPWpGaD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	6.74e-05	0.00197	CbGpPWpGaD
Zolpidem—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.72e-05	0.00196	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	6.69e-05	0.00196	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	6.57e-05	0.00192	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—MAPK1—head and neck cancer	6.55e-05	0.00191	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	6.27e-05	0.00183	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	6.23e-05	0.00182	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	6.18e-05	0.00181	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	5.94e-05	0.00174	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	5.86e-05	0.00171	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	5.85e-05	0.00171	CbGpPWpGaD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	5.77e-05	0.00169	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	5.76e-05	0.00168	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	5.75e-05	0.00168	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	5.71e-05	0.00167	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	5.68e-05	0.00166	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	5.63e-05	0.00165	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	5.61e-05	0.00164	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	5.6e-05	0.00164	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	5.6e-05	0.00164	CbGpPWpGaD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	5.51e-05	0.00161	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	5.46e-05	0.0016	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	5.42e-05	0.00158	CbGpPWpGaD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	5.41e-05	0.00158	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	5.4e-05	0.00158	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	5.39e-05	0.00157	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	5.37e-05	0.00157	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	5.34e-05	0.00156	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	5.28e-05	0.00154	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—HRAS—head and neck cancer	5.26e-05	0.00154	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—UROD—head and neck cancer	5.22e-05	0.00153	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	5.15e-05	0.00151	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	5.07e-05	0.00148	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	5.03e-05	0.00147	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	4.94e-05	0.00144	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	4.88e-05	0.00143	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	4.82e-05	0.00141	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—UROD—head and neck cancer	4.81e-05	0.0014	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—UROD—head and neck cancer	4.76e-05	0.00139	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—AKT1—head and neck cancer	4.64e-05	0.00136	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	4.63e-05	0.00135	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	4.61e-05	0.00135	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	4.56e-05	0.00133	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	4.5e-05	0.00131	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—HRAS—head and neck cancer	4.34e-05	0.00127	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	4.32e-05	0.00126	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—MAPK1—head and neck cancer	4.14e-05	0.00121	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—HRAS—head and neck cancer	4.14e-05	0.00121	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—UROD—head and neck cancer	4.07e-05	0.00119	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—HRAS—head and neck cancer	4.07e-05	0.00119	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.05e-05	0.00118	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—HRAS—head and neck cancer	4.04e-05	0.00118	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4e-05	0.00117	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—HRAS—head and neck cancer	3.97e-05	0.00116	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.96e-05	0.00116	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—MAPK1—head and neck cancer	3.95e-05	0.00115	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—NAT2—head and neck cancer	3.88e-05	0.00113	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—MAPK1—head and neck cancer	3.88e-05	0.00113	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—MAPK1—head and neck cancer	3.86e-05	0.00113	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—MAPK1—head and neck cancer	3.79e-05	0.00111	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	3.77e-05	0.0011	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—NAT2—head and neck cancer	3.76e-05	0.0011	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	3.72e-05	0.00109	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.7e-05	0.00108	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	3.57e-05	0.00104	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	3.52e-05	0.00103	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—HRAS—head and neck cancer	3.47e-05	0.00101	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—DPYD—head and neck cancer	3.4e-05	0.000994	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—HRAS—head and neck cancer	3.32e-05	0.000971	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—MAPK1—head and neck cancer	3.31e-05	0.000967	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—DPYD—head and neck cancer	3.3e-05	0.000964	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—YAP1—head and neck cancer	3.23e-05	0.000944	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—HRAS—head and neck cancer	3.17e-05	0.000926	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.16e-05	0.000923	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—UROD—head and neck cancer	3.14e-05	0.000918	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—YAP1—head and neck cancer	3.13e-05	0.000915	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—HRAS—head and neck cancer	3.12e-05	0.00091	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—HRAS—head and neck cancer	3.1e-05	0.000904	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—HRAS—head and neck cancer	3.04e-05	0.000888	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—NAT2—head and neck cancer	2.81e-05	0.00082	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—HRAS—head and neck cancer	2.66e-05	0.000776	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—DPYD—head and neck cancer	2.46e-05	0.000719	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.35e-05	0.000687	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—YAP1—head and neck cancer	2.34e-05	0.000682	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.3e-05	0.000673	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.28e-05	0.000666	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NAT2—head and neck cancer	2.17e-05	0.000634	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.1e-05	0.000614	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.08e-05	0.000608	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.05e-05	0.000599	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NAT2—head and neck cancer	2e-05	0.000583	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NAT2—head and neck cancer	1.98e-05	0.000578	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—TYMS—head and neck cancer	1.94e-05	0.000567	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GSTM1—head and neck cancer	1.92e-05	0.00056	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—DPYD—head and neck cancer	1.9e-05	0.000556	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—TYMS—head and neck cancer	1.88e-05	0.000549	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GSTM1—head and neck cancer	1.86e-05	0.000543	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GPX1—head and neck cancer	1.84e-05	0.000536	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CYP1A1—head and neck cancer	1.82e-05	0.000531	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—YAP1—head and neck cancer	1.81e-05	0.000527	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.8e-05	0.000524	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GPX1—head and neck cancer	1.78e-05	0.00052	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.78e-05	0.000519	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CYP1A1—head and neck cancer	1.76e-05	0.000515	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—DPYD—head and neck cancer	1.75e-05	0.000511	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—DPYD—head and neck cancer	1.73e-05	0.000507	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NAT2—head and neck cancer	1.69e-05	0.000494	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—YAP1—head and neck cancer	1.66e-05	0.000485	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—YAP1—head and neck cancer	1.65e-05	0.000481	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—DPYD—head and neck cancer	1.48e-05	0.000433	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.45e-05	0.000423	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—YAP1—head and neck cancer	1.41e-05	0.000411	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—TYMS—head and neck cancer	1.4e-05	0.00041	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSTM1—head and neck cancer	1.39e-05	0.000405	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.36e-05	0.000396	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GPX1—head and neck cancer	1.33e-05	0.000388	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYP1A1—head and neck cancer	1.31e-05	0.000384	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NAT2—head and neck cancer	1.3e-05	0.000381	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.24e-05	0.000361	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.18e-05	0.000346	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—DPYD—head and neck cancer	1.14e-05	0.000334	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—YAP1—head and neck cancer	1.09e-05	0.000317	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—TYMS—head and neck cancer	1.08e-05	0.000317	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PTGS2—head and neck cancer	1.08e-05	0.000316	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.08e-05	0.000315	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.07e-05	0.000313	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.06e-05	0.000309	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PTGS2—head and neck cancer	1.05e-05	0.000306	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GPX1—head and neck cancer	1.03e-05	0.0003	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.02e-05	0.000297	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—TYMS—head and neck cancer	9.97e-06	0.000291	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—TYMS—head and neck cancer	9.88e-06	0.000289	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTM1—head and neck cancer	9.86e-06	0.000288	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTM1—head and neck cancer	9.77e-06	0.000285	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GPX1—head and neck cancer	9.44e-06	0.000276	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PTEN—head and neck cancer	9.43e-06	0.000275	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GPX1—head and neck cancer	9.36e-06	0.000273	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYP1A1—head and neck cancer	9.34e-06	0.000273	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYP1A1—head and neck cancer	9.26e-06	0.000271	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.22e-06	0.000269	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PTEN—head and neck cancer	9.14e-06	0.000267	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—TYMS—head and neck cancer	8.45e-06	0.000247	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTM1—head and neck cancer	8.35e-06	0.000244	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.35e-06	0.000244	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GPX1—head and neck cancer	8e-06	0.000234	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYP1A1—head and neck cancer	7.92e-06	0.000231	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PTGS2—head and neck cancer	7.81e-06	0.000228	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.61e-06	0.000222	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PTEN—head and neck cancer	6.81e-06	0.000199	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CA—head and neck cancer	6.65e-06	0.000194	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—TYMS—head and neck cancer	6.52e-06	0.00019	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.5e-06	0.00019	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CA—head and neck cancer	6.45e-06	0.000188	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTM1—head and neck cancer	6.44e-06	0.000188	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GPX1—head and neck cancer	6.17e-06	0.00018	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYP1A1—head and neck cancer	6.11e-06	0.000178	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PTGS2—head and neck cancer	6.04e-06	0.000176	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PTGS2—head and neck cancer	5.56e-06	0.000162	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PTGS2—head and neck cancer	5.51e-06	0.000161	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—AKT1—head and neck cancer	5.43e-06	0.000159	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PTEN—head and neck cancer	5.27e-06	0.000154	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—AKT1—head and neck cancer	5.27e-06	0.000154	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PTEN—head and neck cancer	4.85e-06	0.000142	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CA—head and neck cancer	4.81e-06	0.00014	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PTEN—head and neck cancer	4.8e-06	0.00014	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PTGS2—head and neck cancer	4.71e-06	0.000138	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PTEN—head and neck cancer	4.11e-06	0.00012	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—AKT1—head and neck cancer	3.93e-06	0.000115	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CA—head and neck cancer	3.72e-06	0.000109	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PTGS2—head and neck cancer	3.63e-06	0.000106	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CA—head and neck cancer	3.42e-06	9.99e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CA—head and neck cancer	3.39e-06	9.9e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PTEN—head and neck cancer	3.17e-06	9.26e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—AKT1—head and neck cancer	3.04e-06	8.87e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CA—head and neck cancer	2.9e-06	8.46e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—AKT1—head and neck cancer	2.79e-06	8.16e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—AKT1—head and neck cancer	2.77e-06	8.09e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—AKT1—head and neck cancer	2.37e-06	6.91e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.24e-06	6.53e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—AKT1—head and neck cancer	1.83e-06	5.33e-05	CbGpPWpGaD
